Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro
- 19 September 2005
- journal article
- research article
- Published by Elsevier
- Vol. 168 (1) , 128-137
- https://doi.org/10.1016/j.jneuroim.2005.01.024
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Therapeutic role of mitoxantrone in multiple sclerosisPharmacology & Therapeutics, 2005
- Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-γ production of CD8+ T cells in secondary progressive multiple sclerosisJournal of Neuroimmunology, 2004
- Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategiesExpert Opinion on Investigational Drugs, 2003
- Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotectionTrends in Pharmacological Sciences, 2003
- New concepts in the immunopathogenesis of multiple sclerosisNature Reviews Neuroscience, 2002
- Evaluation of mitoxantrone for the treatment of multiple sclerosisExpert Opinion on Investigational Drugs, 2000
- Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple SclerosisThe Journal of Clinical Pharmacology, 1995
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983